Global Molecular Cytogenetics Market, 2022 - Increase in Predictive and Presymptomatic Genetic Testing
DUBLIN, October 13, 2017 /PRNewswire/ --
The "Molecular Cytogenetics Market - Global Opportunity Analysis and Industry Forecasts to 2022" report has been added to Research and Markets' offering.
Global molecular cytogenetics market is expected to reach USD 2,266.4 million by 2022, supported by a CAGR of 11% during the forecast period of 2017 to 2022
The global molecular cytogenetics market is mainly driven by increasing focus on preventive healthcare measures, increasing genetic abnormalities, rising aging population and subsequent increase in
various chronic diseases, growing need to reduce mounting healthcare cost, and increasing focus on clinical and research diagnosis.
Moreover, increasing focus on targeted based therapies and growing predictive and presymptomatic genetic testing further provides significant opportunities in this market. However, lack of
awareness about emerging diagnosis technologies, high cost of diagnosis, unfavourable reimbursement scenario, and technical limitations and complexities of the equipment inhibits the growth of the
market to some extent.
The global molecular cytogenetics market is mainly segmented by technique (fluorescence in situ hybridization, comparative genomic hybridization, in situ hybridization, karyotyping, and banding
techniques), by product (instruments, kits and reagents, software, services, and consumable/accessories ), by application (oncology, genetic disorders, personalized medicines, and other), and by
end user (pharmaceuticals and biotechnological companies, clinical and diagnostic laboratories, and academic institutes).
The large share of this region is primarily attributed to the increased funding in medical research, stringent drug development regulations which demand molecular cytogenetics techniques, growing
aging population and thereby prevalence of various chronic diseases, and direct & indirect financial investments in the pharma biotech companies.
However, Asia-Pacific region possesses lucrative growth potential for the molecular cytogenetic market during the forecast period owing to the increasing demand in
China and India, growing population, various technological advancements, growing investment from government & non-government
bodies, and growing pharma biotech industry in the region.
Scope of the Report
Market by Technique:
- Fluorescence In Situ Hybridization
- Comparative Genomic Hybridization
-
- Chromosomal CGH
- Array CGH
- In Situ Hybridization
- Karyotyping
-
- Spectral Karyotyping
- Virtual Karyotyping
- Banding Techniques
-
- G banding
- Q banding
- R banding
- C banding
- T banding
Market by Product: